Correlation Between Dynavax Technologies and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Dynavax Technologies and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Tarsus Pharmaceuticals.
Diversification Opportunities for Dynavax Technologies and Tarsus Pharmaceuticals
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dynavax and Tarsus is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dynavax Technologies and Tarsus Pharmaceuticals
Given the investment horizon of 90 days Dynavax Technologies is expected to generate 8.45 times less return on investment than Tarsus Pharmaceuticals. But when comparing it to its historical volatility, Dynavax Technologies is 1.91 times less risky than Tarsus Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1,655 in Tarsus Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 3,169 from holding Tarsus Pharmaceuticals or generate 191.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dynavax Technologies vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Dynavax Technologies |
| Tarsus Pharmaceuticals |
Dynavax Technologies and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dynavax Technologies and Tarsus Pharmaceuticals
The main advantage of trading using opposite Dynavax Technologies and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Dynavax Technologies vs. Alkermes Plc | Dynavax Technologies vs. Neurocrine Biosciences | Dynavax Technologies vs. Intracellular Th | Dynavax Technologies vs. Aquestive Therapeutics |
| Tarsus Pharmaceuticals vs. Capricor Therapeutics | Tarsus Pharmaceuticals vs. Soleno Therapeutics | Tarsus Pharmaceuticals vs. Bio Path Holdings | Tarsus Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |